WA
PFE icon

WPG Advisers’s Pfizer PFE Stock Holding History

WPG Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.8K Buy
3,354
+530
+19% +$13.9K 0.05% 217
2026
Q1 		$79.3K Sell
2,824
-4,250
-60% -$113K 0.06% 182
2025
Q4 		$176K Buy
7,074
+3,022
+75% +$76.2K 0.13% 101
2025
Q3 		$103K Buy
4,052
+2,191
+118% +$54.1K 0.08% 152
2025
Q2 		$45.1K Buy
1,861
+498
+37% +$11.6K 0.04% 297
2025
Q1 		$34.5K Buy
1,363
+370
+37% +$9.68K 0.03% 352
2024
Q4 		$26.3K Buy
+993
New +$26.9K 0.02% 402

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WPG Advisers's PFE Position: Q2 2026 in Review

WPG Advisers increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $13.9K and bringing the position to 3,354 shares worth $80.8K. The position accounts for 0.05% of the portfolio, ranked #217.

WPG Advisers first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $176K in Q4 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • WPG Advisers held 3,354 shares of Pfizer worth $80.8K as of Q2 2026.
  • WPG Advisers bought 530 Pfizer shares in Q2 2026, an estimated $13.9K.
  • Pfizer made up 0.05% of WPG Advisers's portfolio in Q2 2026, its #217 holding.
  • WPG Advisers first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Pfizer position peaked at $176K in Q4 2025.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.